Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Conclusions. This study showed that unrelated donor BMT can successfully cure a proportion of patients with thalassemia. Remarkably, despite 57% of patients were in class 3 of risk the 5-year OS and TFS rates were 90%. We conclude that class 3 patients with thalassemia who have a suitably matched unrelated donor should not be denied the option of transplantation.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Gaziev, J., Isgro, A., Paciaroni, K., Marziali, M., De Angelis, G., Ribersani, M., Alfieri, C., Andreani, M. Tags: 732. Clinical Allogeneic Transplantation: Results Source Type: research